Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer

Overview of attention for article published in Molecular Cancer, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Anti-cancer drug resistance diagnostic biomarker composition comprising ITGB3 protein

Grant KR-102466637-B1

Republic of Korea

Anti-cancer drug resistance diagnostic biomarker composition comprising ITGB3 protein

Application KR-20200081306-A

Republic of Korea

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.